A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF
- PMID: 22068587
- DOI: 10.1093/hmg/ddr510
A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF
Abstract
Receptor activator of nuclear factor-κB ligand (RANKL), a trimeric tumor necrosis factor (TNF) superfamily member, is the central mediator of osteoclast formation and bone resorption. Functional mutations in RANKL lead to human autosomal recessive osteopetrosis (ARO), whereas RANKL overexpression has been implicated in the pathogenesis of bone degenerative diseases such as osteoporosis. Following a forward genetics approach using N-ethyl-N-nitrosourea (ENU)-mediated random mutagenesis, we generated a novel mouse model of ARO caused by a new loss-of-function allele of Rankl with a glycine-to-arginine mutation at codon 278 (G278R) at the extracellular inner hydrophobic F β-strand of RANKL. Mutant mice develop severe osteopetrosis similar to Rankl-deficient mice, whereas exogenous administration of recombinant RANKL restores osteoclast formation in vivo. We show that RANKL(G278R) monomers fail to assemble into homotrimers, are unable to bind and activate the RANK receptor and interact with wild-type RANKL exerting a dominant-negative effect on its trimerization and function in vitro. Since G278 is highly conserved within the TNF superfamily, we identified that a similar substitution in TNF, G122R, also abrogated trimerization, binding to TNF receptor and consequently impaired TNF biological activity. Notably, SPD304, a potent small-molecule inhibitor of TNF trimerization that interacts with G122, also inhibited RANKL activity, suggesting analogous inhibitory mechanisms. Our results provide a new disease model for ARO and identify a functional amino acid in the TNF-like core domain essential for trimer formation both in RANKL and in TNF that could be considered a novel potential target for inhibiting their biological activities.
Similar articles
-
Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.Free Radic Biol Med. 2006 May 1;40(9):1483-93. doi: 10.1016/j.freeradbiomed.2005.10.066. Epub 2005 Dec 9. Free Radic Biol Med. 2006. PMID: 16632109
-
Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation.Mol Endocrinol. 2009 Jan;23(1):35-46. doi: 10.1210/me.2007-0465. Epub 2008 Nov 13. Mol Endocrinol. 2009. PMID: 19008464 Free PMC article.
-
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.J Bone Miner Res. 2001 Oct;16(10):1787-94. doi: 10.1359/jbmr.2001.16.10.1787. J Bone Miner Res. 2001. PMID: 11585342
-
Crystal structure of RANK ligand involved in bone metabolism.Vitam Horm. 2004;67:19-33. doi: 10.1016/S0083-6729(04)67002-6. Vitam Horm. 2004. PMID: 15110169 Review.
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
Cited by
-
Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques.Front Endocrinol (Lausanne). 2021 Nov 30;12:731217. doi: 10.3389/fendo.2021.731217. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34938269 Free PMC article. Review.
-
Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanisms.J Cell Physiol. 2017 Dec;232(12):3798-3807. doi: 10.1002/jcp.25862. Epub 2017 May 11. J Cell Physiol. 2017. PMID: 28213978 Free PMC article.
-
RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.Clin Dev Immunol. 2013;2013:412768. doi: 10.1155/2013/412768. Epub 2013 May 15. Clin Dev Immunol. 2013. PMID: 23762088 Free PMC article. Review.
-
A splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in mice.PLoS One. 2014 Aug 11;9(8):e104237. doi: 10.1371/journal.pone.0104237. eCollection 2014. PLoS One. 2014. PMID: 25111180 Free PMC article.
-
Osteopetrosis: genetics, treatment and new insights into osteoclast function.Nat Rev Endocrinol. 2013 Sep;9(9):522-36. doi: 10.1038/nrendo.2013.137. Epub 2013 Jul 23. Nat Rev Endocrinol. 2013. PMID: 23877423 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases